Blogs and News

The clinical trials news has been dominated by studies showing underrepresentation in clinical trials, and experts calling for an end to it. But why is representation important, and how is it affecting trials? Clinical trials have been an established way of testing...

At Siron Clinical, people are our biggest strength. Here we meet Ingrid Meine, who joined the Siron Clinical team as Clinical Trial Manager.

The pandemic accelerated innovation around clinical trial decentralization, but remote approaches are here to stay. Here are five ways decentralization can help you succeed with your clinical trial.

To get the best start with a clinical trial, we carry out a site initiation visit (SIV). In this post, we look at what that entails and how we ensure it sets the trial off in a positive direction.

There are many different types of clinical trial design, but most of the approaches we take to clinical research have been around for many years. Innovation in trial design could help improve outcomes and efficiency – and the FDA has shared some examples.

Clinical trials in the EU are changing in 2022 – the new EU Clinical Trials Regulation comes into force, backed by the Clinical Trials Information System (CTIS) and driven by an initiative to transform clinical trials. Here is a round-up of what it means for running a clinical trial in the EU.

Clinical trials are complex, which means they involve a lot of work and require a range of skills and experience. It can be daunting when you start planning a clinical trial – how will you manage everything that’s needed, especially if you have a small team?

One of the key drivers of our success as a CRO is our extensive experience with clinical trials across phase I and II trials, and in therapeutic areas including dermatology, oncology, pediatric and orphan indications.

How are the results of clinical trials applied? A clinical trial can generate a huge amount of data. Collecting, storing and managing that data is challenging, especially for large, complex, multi-site and multinational trials.

Your drug has passed through the phase I clinical trial and you’ve selected and contacted the sites you want to work with. Now it’s time to get your trial up and running in the EU. What do you do? Let’s walk through the process step by step.